Bioinformatics and the Politics of Innovation in the Life Sciences: Science and the State in the United Kingdom, China, and India

Science Technology and Human Values

Volumn 41, Issue 5, 2016, Pages 793-826

  Salter, Brian ^a   Zhou, Yinhua ^a   Datta, Saheli ^a   Salter, Charlotte ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

governance; markets economies; other; politics; power

Indexed keywords

EID: 84981736373     PISSN: 01622439     EISSN: 15528251     Source Type: Journal    
DOI: 10.1177/0162243916631022     Document Type: Article

References (82)

1. R.AiD.Wang. 2011. “Analysis of Bioinformatics and Computational Biology Topics in Eleventh Five-year Plan National High Technology Research and Development Program.” China Biotechnology31 (12): 126–32.
2. BBSRC (Biotechnology and Biological Sciences Research Council). 2012. Bioscience for Society. A Ten Year Vision. ‘Towards Predictive Biology’. Accessed August 25, 2014. http://www.bbsrc.ac.uk/web/FILES/Publications/bbsrc_vision.pdf.
3. D.Botstein1999. “The Biomedical Information Science and Technology Initiative.” National Institute of Health Report. Accessed October 24, 2014. http://acd.od.nih.gov/agendas/060399_Biomed_Computing_WG_RPT.htm.
4. D.Butler2001. “Are You Ready for the Revolution?” Nature409 (6822): 758–60.
5. C.CaoR.P.Suttmeier. 2001. “China’s New Scientific Elite: Distinguished Young Scientists, the Research Environment and Hopes for Chinese Science.” The China Quarterly168:960–84.
6. P.Cerny1997. “Paradoxes of the Competition State: The Dynamics of Political Globalisation.” Government and Opposition32 (2): 251–74.
7. China Daily USA. 2013. “New Green Revolution to End Hunger. 27th March.” Accessed October 13, 2015. http://usa.chinadaily.com.cn/opinion/2013-03/27/content_16347822.htm.
8. P.Chow-WhiteM.Garcia-Sancho. 2012. “Biodirectional Shaping and Spaces of Convergence: Interactions between Biology and Computing from the First DNA Sequencers to Global Genome Databases.” Science, Technology, & Human Values37 (1): 124–64.
9. S.D.CookseySir David. 2006. A Review of UK Health Research Funding. London: Stationery Office.
10. S.Datta2014. “Bioinformatics Policy of India (1986-2013): A Report.” Working Paper 43, Global Biopolitics Research Centre, Department of Political Economy, King’s College London, UK. Accessed November 17, 2014. http://www.kcl.ac.uk/sspp/departments/politicaleconomy/research/biopolitics/publications/workingpapers/Working-Paper-43-(2014).pdf.
11. DBT (Department of Biotechnology). 2007. National Biotechnology Development Strategy (Biotech Strategy I). New Delhi: Department of Biotechnology, Ministry of Science & Technology, Government of India. Accessed October 2, 2014. http://dbtindia.nic.in/biotechstrategy/National%20Biotechnology%20Development%20Strategy.pdf.
12. DBT (Department of Biotechnology). 2014. National Biotechnology Development Strategy (Biotech strategy II). New Delhi: Department of Biotechnology, Ministry of Science & Technology, Government of India. Accessed October 2, 2014. http://dbtindia.nic.in/docs/NBDS_2014.pdf.
13. Department of Biotechnology, Ministry of Science. 2001. Biotechnology: A Vision Ten Year Perspective. New Delhi: Government of India.
14. Department of Health. 2003. Our Inheritance, Our Future. Realising the Potential of Genetics in the NHS. Cm 5791-II. London, UK: Stationery Office.
15. Department of Health. 2009. Government Response to the House of Lords Science and Technology Committee Inquiry into Genomic Medicine. Cm 7757. London, UK: Stationery Office.
16. EBI (European Bioinformatics Institute). 2014. About Us. Accessed July 10, 2015. http://www.ebi.ac.uk/about.
17. EPSRC (Engineering and Physical Sciences Research Council). 2014. “BBSRC/MRC/EPSRC/NERC Joint Statement on Handling Bioinformatics Applications.” Accessed August 26, 2014. http://www.epsrc.ac.uk/research/ourportfolio/themes/ict/introduction/jointstatementbioinf/.
18. J.FarquharK.Sunda Rajan. 2014. “Introduction.” East Asian Science, Technology and Society: An International Journal8 (4): 383–89(Special issue).
19. FICCI (Federation of Indian Chambers of Commerce and Industry). 2012. “Biotechnology Landscape in India.” Accessed October 29, 2014. http://www.ficci.com/publication-page.asp?spid=20337.
20. P.GalisonB.Hevly, eds. 1992. Big Science. Stanford: Stanford University Press.
21. Genome 10K Consortium of Scientists. 2015. Accessed October 14, 2015. https://genome10k.soe.ucsc.edu/collaborators.
22. Genomics England. 2014. “About Genomics England.” Accessed October 9, 2014. http://www.genomicsengland.co.uk/about-genomics-england/.
23. M.HarveyA.McMeekin. 2002. UK Bioinformatics: Current Landscapes and Future Horizons. London, UK: Department of Trade and Industry.
24. M.HarveyA.McMeekin. 2007. Public or Private Economies of Knowledge. Turbulence in the Biological Sciences. Cheltenham, UK: Edward Elgar.
25. M.HarveyA.McKeekin. 2010. “Public or Private Economies of Knowledge: The Economics of Diffusion and Appropriation of Bioinformatics Tools.” International Journal of the Commons4 (1): 481–506.
26. C.Hay2004. “Re-stating Politics, Re-politicising the State: Neo-liberalism, Economic Imperatives and the Rise of the Competition State.” Political Quarterly75 (1): 38–50.
27. T.HeyS.TansleyK.Tolle. 2009. The Fourth Paradigm. Data-intensive Scientific Discovery. Redmond, WA: Microsoft Research.
28. House of Lords Science and Technology Committee. 2001. Human Genetic Databases: Challenges and Opportunities. Fourth Report, Session 2000-01. HL Paper 57, Stationery Office, London, UK.
29. House of Lords Science and Technology Committee. 2009. Genomic Medicine. Second Report, Session 2008-09. HL Paper 107-I, Stationery Office, London, UK.
30. R.S.HunterA.H.OswaldB.G.Charlton. 2009. “The Elite Brain Drain.” The Economic Journal119 (538): F231–51.
31. India DBT (Department of Biotechnology). 2014. “BTIS NET. Biotechnology Information System (BTIS). A National Bioinformatics Network. Supercomputer Facility Biogrid India.” Accessed September 6, 2014. http://dbtindia.nic.in/uniquepage.asp?id_pk=63.
32. India Department of Biotechnology and Ministry of Science and Technology. 2004. Bioinformatics Policy of India. New Delhi: Apex Bioinformatics Centre, Department of Biotechnology.
33. S.Jasanoff1994. The Fifth Branch: Science Advisers as Policy Makers. Harvard, MA: Harvard University Press.
34. S.Jasanoff, ed. 2004. States of Knowledge: The Co-production of Science and Social Order. London, UK: Routledge.
35. K.S.Jayaraman2005. “Among the Best.” Nature Outlook: India, Nature436 (28 July): 483.
36. B.Jessop2002. The Future of the Capitalist State. Oxford, UK: Polity Press, Oxford.
37. Y.T.Kim1999. “Neoliberalism and the Decline of the Developmental State.” Journal of Contemporary Asia29 (4): 441–62.
38. C.-S.LeeA.Schrank. 2010. “Incubating Innovation or Cultivating Corruption? The Developmental State and the Life Sciences in Asia.” Social Forces88 (3): 1231–55.
39. T.Lenoir1999. “Shaping Biomedicine as an Information Science.” In Proceedings of the 1998 Conference on the History and Heritage of the Science Information Systems, edited by, 27–45. Medford: ASIS.
40. T.LenoirM.Hays. 2000. “The Manhattan Project for Biomedicine.” In Controlling Our Destinies: Historical, Philosophical, Ethical and Theological Perspectives on the Human Genome Project Indiana, edited by, 19–46. Notre Dame, IN: University of Notre Dame.
41. S.Leonelli2012a. “Classificatory Theory in Data-intensive Science: The Case of Open Biomedical Ontologies.” International Studies in the Philosophy of Science26 (1): 47–65.
42. S.Leonelli2012b. “Introduction: Making Sense of Data-intensive Research in the Biological and Biomedical Sciences.” Studies in the History and the Philosophy of the Biological and Biomedical Sciences: Part C43 (1): 1–3.
43. S.Leonelli2014. “What Difference Does Quantity Make? On the Epistemology of Big Data in Biology.” Big Data and Society1 (1): 1–11.
44. S.LeonelliR.Ankeny. 2012. “Re-thinking Organisms: The Impact of Databases on Model Organism Biology.” Studies in History and Philosophy of Biological and Biomedical Sciences43 (1): 29–36.
45. J.LewisA.Bartlett. 2013. “Inscribing a Discipline: Tensions in the Field of Bioinformatics.” New Genetics and Society32 (3): 243–63.
46. Z.LiJ.ZhangK.WenH.ThorsteinsdóttirU.QuachP.A.SingerA.S.Daar. 2004. “Health Biotechnology in China: Reawakening of a Giant.” Nature Biotechnology22 (Supplement): DC13–18.
47. N.M.LuscombeD.GreenbaumM.Gerstein. 2001. “What is Bioinformatics? A Proposed Definition and Overview of the Field.” Methods of Information in Medicine40 (4): 346–58.
48. V.Mayer-SchonbergerK.Cukier. 2013. Big Data: A Revolution that will Transform How We Live, Work and Think. New York: Houghton, Mifflin, Harcourt.
49. MRC (Medical Research Council). 2014. “Medical Bioinformatics: Science Minister David Willetts Announces £32 Million towards Improving Data Research.” Accessed August 24, 2014. http://www.mrc.ac.uk/news-events/news/medical-bioinformatics-science-minister-david-willetts-announces-32-million-towards-improving-data-research/.
50. MOST (Ministry of Science and Technology). 2012a. 12th Five Year Plan for the Medical and Pharmaceutical Industry. Beijing, China: MOST.
51. MOST (Ministry of Science and Technology). 2012b. National Basic Research Programme (973 programme). Beijing, China: MOST.
52. C.Mukerji1989. A Fragile Power: Scientists and the State. Princeton, NJ: Princeton University Press.
53. M.Mulkay1976. “The Mediating Role of the Scientific Elite.” Social Studies of Science6:445–70.
54. Nature. 2010. “China Spurs Pharma Innovation.” Nature Reviews Drug Discovery9 (8): 581–82.
55. NSF (National Science Foundation). 2014. Engineering and Science Indicators 2014. Accessed November 16, 2014. http://www.nsf.gov/statistics/seind14/index.cfm/chapter-4/c4h.htm.
56. Z.Onis1991. “The Logic of the Developmental State.” Comparative Politics24 (1): 109–26.
57. C.OuzounisA.Valencia. 2003. “Early Bioinformatics: The Birth of a Discipline.” Bioinformatics19 (17): 2176–90.
58. B.PendersK.HorstmanR.Vos. 2008. “Walking the Line between Lab and Computation: The ‘Moist’ Zone.” BioScience58 (8): 747–55.
59. Planning Commission. 2002. Tenth Five Year Plan 2002-2007: Vol II. Sectoral Policies and Programs. Accessed July 10, 2015. http://planningcommission.nic.in/plans/planrel/fiveyr/10th/volume2/10th_vol2.pdf.
60. Planning Commission. 2013. Twelfth Five Year Plan 2012-17. Accessed October 14, 2014. http://planningcommission.nic.in/plans/planrel/fiveyr/welcome.html.
61. T.Reichhardt1999. “It’s Sink or Swim as the Tidal Wave of Data Approaches.” Nature399 (6736): 517–20.
62. B.Salter2009a. “State Strategies and the Global Knowledge Economy: The Geopolitics of Regenerative Medicine.” Geopolitics14 (1): 1–31.
63. B.Salter2009b. “China, Globalisation and Health Biotechnology Innovation: Venture Capital and the Adaptive State.” East Asian Science and Technology: An International Journal3 (4): 401–20.
64. B.Salter2013. “Governing Innovation Paths in Regenerative Medicine: The European and Global Struggle for Political Advantage.” In The Global Dynamics of Regenerative Medicine: A Social Science Critique, edited by, 194–216. Basingstoke, UK: Palgrave Macmillan.
65. M.Solovey2001. “Science and the State during the Cold War: Blurred Boundaries and a Contested Legacy.” Social Studies of Science31 (2): 165–70.
66. State Council of the PRC. 2009. Some Policies Promoting the Development of Bio-industry. Beijing, China: State Council.
67. State Council of the PRC. 2010. Decision of the State Council on Accelerating the Fostering and Development of Strategic Emerging Industries. Beijing, China: State Council.
68. State Council of the PRC. 2012. Notice of the State Council on Issuing the Bio-industry Development Plan. Beijing, China: State Council.
69. H.Stevens2013. Life Out of Sequence: A Data Driven History of Bioinformatics. Chicago: University of Chicago Press.
70. R.P.SuttmeierC.Cao. 1999. “China Faces the New Industrial Revolution: Achievement and Uncertainty in the Search for Research and Innovation Strategies.” Asian Perspective23 (3): 153–200.
71. E.Thacker2006. The Global Genome: Biotechnology, Politics, and Culture. Cambridge, MA: The MIT Press.
72. UK Department for Business, Innovation and Skills. 2012. Strategy for UK Life Sciences. One Year On. Office for Life Sciences. London, UK: Department for Business, Innovation and Skills.
73. R.Wade2003. “What Strategies Are Viable for Developing Countries Today? The World Trade Organisation and the shrinking of development space.” Review of International Political Economy10 (4): 621–44.
74. C.S.WagnerL.Leydesdorff. 2005. “Network Structure, Self-organization, and the Growth of International Collaboration in Science.” Research Policy34 (10): 1608–18.
75. L.WeiY.Lu. 2008. Bioinformatics in China: A Personal View.”PLoS Computational Biology4 (4): 1–11.
76. L.Weiss2000. “Developmental States in Transition: Adapting, Dismantling, Innovating, not ‘Normalising’. The Pacific Review13 (1): 21–55.
77. R.Whitley1976. “Umbrella and Polytheistic Scientific Disciplines and their Elites.” Social Studies of Science6 (1976): 471–97.
78. J.Wong2005. “Re-making the Developmental State in Taiwan: The Challenges of Biotechnology.” International Political Science Review26 (2): 169–91.
79. J.Wong2011. Betting on Biotech: Innovation and the Limits of Asia’s Developmental State. Ithaca, NY: Cornell University Press.
80. Working Group on Biotechnology. 2011. Report of the Working Group on Biotechnology 12th Plan (2012-2017). Accessed October 27, 2014. http://dst.gov.in/about_us/12th-plan/10-wg_dbt2905-report.pdf.
81. Y.Wu2004. “Rethinking the Taiwanese Developmental State.” The China Quarterly177: 91–114.
82. Y.Zhou2014. “Bioinformatics Policy in China: A Report.” Working Paper 44, Global Biopolitics Research Centre, Department of Political Economy, King’s College London, UK. Accessed June 6, 2015. http://www.kcl.ac.uk/sspp/departments/politicaleconomy/research/biopolitics/publications/workingpapers/Working-Paper-44-(2014).pdfGlobal Biopolitics Research Centre, Department of Political Economy, King’s College London.